29th Annual ROTH Conference

March 12-15, 2017

Ritz Carlton, Dana Point, CA

ROTH Capital Partners' 29th Annual Conference is one of the largest of its kind in the United States. With roughly 500 participating companies and over 4,000 attendees, Roth will feature presentations from hundreds of public and private companies in a variety of sectors including health care; technology, Internet and media; cleantech, industrial growth and solar; consumer; oil and gas/mining and minerals; and business services. The three-and-a-half day event will include company presentations and small group meetings, as well as panels, entertainment and more. This gathering of institutional investors, private equity investors, VCs, company executives and service providers has become a must attend event for anyone working in the small and mid-cap space. For more information visit www.Roth.com

Presenting Companies: A-E F-J K-O P-T U-Z

22nd Century (XXII)

22nd Century (NYSE: XXII) is a plant biotech company providing technology that allows for the level of nicotine and other nicotinic alkaloids in tobacco plants and the level of cannabinoids in cannabis plants to be decreased or increased through genetic engineering and plant breeding. The company develops smoking cessation products and modified risk tobacco products for smokers who are unable or unwilling to quit smoking and who may be interested in cigarettes, which reduce exposure to nicotine or to certain tobacco smoke toxins and/or pose a lower health risk than conventional cigarettes. For more information, visit the company's website at www.xxiicentury.com.

Abeona Therapeutics (ABEO)

Abeona Therapeutics (NASDAQ: ABEO) is a clinical-stage biopharmaceutical company developing gene therapies for life-threatening rare genetic diseases. Abeona's lead programs include ABO-102 and ABO-101, adeno-associated virus based gene therapies for Sanfilippo syndrome. Abeona is also developing EB-101 for recessive dystrophic epidermolysis bullosa, EB-201 for epidermolysis bullosa, ABO-201 gene therapy for juvenile Batten disease, ABO-202 gene therapy for treatment of infantile Batten disease, and ABO-301 for Fanconi anemia disorder and ABO-302 using a novel CRISPR/Cas9-based gene editing approach to gene therapy for rare blood diseases. In addition, Abeona has a plasma-based protein therapy pipeline, including SDF Alpha™ for inherited COPD, using its proprietary SDF™ (Salt Diafiltration) ethanol-free process. For more information, visit the company's website at www.abeonatherapeutics.com.

AcelRx Pharmaceuticals (ACRX)

AcelRx Pharmaceuticals (NASDAQ: ACRX) is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. An NDA for DSUVIA (sufentanil sublingual tablet, 30 mcg) was recently submitted to the FDA for review. The company's follow on product, ZALVISO® (sufentanil sublingual tablet system), designed for the management of moderate-to-severe acute pain in adult patients in the hospital setting, is currently enrolling patients in a phase 3 clinical trial, IAP312. For more information, visit the company's website at www.acelrx.com.

Acme United (ACU)

Acme United (NYSE: ACU) is an innovative supplier of cutting devices and safety products for school, home, office, hardware and industrial use. Its leading brands include Westcott®, a major brand for scissors and rulers; Clauss®, which primarily manufactures cutting instruments for professionals in the hardware & industrial, lawn & garden, food processing, sewing and housewares markets; Camillus®, a recognizable brand in the knife industry; fishing gear brand CUDA®; DMT, a manufacturer of large diamond grinding and polishing wheels for industrial application; as well as First Aid Only®, PhysiciansCare® and Pac-Kit®. The company has operations in the United States, Canada, Europe (located in Germany) and Asia (located in Hong Kong and China). For more information, visit the company's website at www.acmeunited.com.

Actinium Pharmaceuticals (ATNM)

Actinium Pharmaceuticals (NYSE: ATNM) is a biopharmaceutical company developing innovative targeted payload immunotherapies for the treatment of advanced cancers. The company's radio-immunotherapy product candidates are based on the combination of the cancer targeting precision of monoclonal antibodies (mAb) that seek out specific types of cells combined with the cytotoxic killing power of radioisotopes that unleash their energy once they have reached their target. For more information, visit the company's website at www.actiniumpharma.com.

Adamis Pharmaceuticals (ADMP)

Adamis Pharmaceuticals (NASDAQ: ADMP) is a specialty biopharmaceutical company focused on developing and commercializing products in the therapeutic areas of respiratory disease and allergy. The company's current specialty pharmaceutical product candidates include the Epinephrine Injection PFS syringe product for use in the emergency treatment of anaphylaxis, APC-1000 and APC-5000 for the treatment of asthma and chronic obstructive pulmonary disease, and APC-2000 for the treatment of bronchospasms. The company's U.S. Compounding, Inc. subsidiary provides prescription compounded medications, including compounded sterile preparations and non-sterile compounds, to patients, physician clinics, hospitals, surgery centers and other clients throughout most of the United States. USC's product offerings broadly include, among others, corticosteroids, hormone replacement therapies, hospital outsourcing products, injectables, urological preparations, ophthalmic preparations, topical compounds for pain and men's and women's health products. For more information, visit the company's website at www.adamispharmaceuticals.com.

Adesto Technologies (IOTS)

Adesto Technologies (NASDAQ: IOTS) provides application-specific, ultra-low power non-volatile memory products. The company has designed and built a portfolio of innovative products with intelligent features to conserve energy and enhance performance, including Fusion Serial Flash, DataFlash®, EcoXiP™ and products based on Conductive Bridging RAM (CBRAM®). CBRAM® is a technology platform that enables 100 times less energy consumption than today's memory technologies without sacrificing speed and performance. Adesto is focused on delivering differentiated solutions and helping its customers usher in the era of the Internet of Things (IoT). For more information, visit the company's website at www.adestotech.com.

Adocia SA (ADCOF)

Adocia SA (OTC: ADCOF) a clinical-stage biotechnology company, develops medicines using therapeutic molecules. Its product pipeline includes BioChaperone PDGF, which is in phase III clinical trials for the treatment of diabetic foot ulcer; BioChaperone Combo insulin that is in phase I/II clinical trials, as well as in pre-clinical stage for the treatment of diabetes; BioChaperone Lispro U100 that is in phase Ib clinical study for type 1 diabetes patients using an insulin pump; BioChaperone human insulin, which is in phase II clinical trials; and DriveIn, which is in preclinical stage for the treatment of oncology, as well as monoclonal antibodies for the treatment of pathologies, such as chronic inflammatory disease or oncology. Adocia has a collaborative research and license agreement with Eli Lilly for the development and commercialization of the BioChaperone Lispro programs. The company was founded in 2005 and is headquartered in Lyon, France. For more information, visit the company's website at www.adocia.fr.

Aduro Biotech (ADRO)

Aduro Biotech (NASDAQ: ADRO) is an immunotherapy company focused on the discovery, development and commercialization of therapies that transform the treatment of challenging diseases. Aduro's technology platforms, which are designed to harness the body's natural immune system, are being investigated in cancer indications and have the potential to expand into autoimmune and infectious diseases. Aduro's LADD technology platform is based on proprietary attenuated strains of Listeria that have been engineered to express tumor-associated antigens to induce specific and targeted immune responses and is being developed as a treatment for multiple indications, including ovarian, lung and prostate cancers, and mesothelioma. Additionally, a personalized form of LADD, or pLADD, is being developed utilizing tumor neoantigens that are specific to an individual patient's tumor. Aduro's STING Pathway Activator platform is designed to activate the intracellular STING receptor, resulting in a potent tumor-specific immune response. ADU-S100 is the first STING Pathway Activator compound to enter the clinic and is currently being evaluated in a phase 1 study in patients with cutaneously accessible metastatic solid tumors or lymphomas. Aduro's B-select monoclonal antibody platform includes a number of immune modulating assets in research and preclinical development. Aduro is collaborating with global pharmaceutical companies to expand its products and technology platforms. For more information, visit the company's website at www.aduro.com.

Advanced Emissions Solutions (ADES)

Advanced Emissions Solutions (NASDAQ: ADES) serves as the holding entity for a family of companies that provide emissions solutions to customers in the power generation and other industries. ADA-ES, Inc. is a wholly-owned subsidiary that provides emissions control solutions for coal-fired power generation and industrial boiler industries. With more than 25 years of experience developing advanced mercury control solutions, ADA delivers proprietary environmental technologies, equipment and specialty chemicals that enable coal-fueled boilers to meet emissions regulations. These solutions enhance existing air pollution control equipment, maximizing capacity and improving operating efficiencies. For more information, visit the company's website at www.advancedemissionssolutions.com.

Adverum (ADVM)

Adverum (NASDAQ: ADVM) is a gene therapy company committed to discovering and developing novel medicines that can offer life-changing benefits to patients living with rare diseases or diseases of the eye who currently have limited or burdensome treatment options. Adverum has a robust pipeline that includes product candidates to treat wet age-related macular degeneration, alpha-1 antitrypsin deficiency, and hereditary angioedema. Leveraging a next-generation adeno-associated virus-based directed evolution platform, the company generates product candidates designed to provide durable efficacy by inducing sustained expression of a therapeutic protein. Adverum has collaboration agreements with Regeneron Pharmaceuticals to research, develop, and commercialize gene therapy products for ophthalmic diseases and Editas Medicine to explore the delivery of genome editing medicines for the treatment of inherited retinal diseases. Adverum has clinical development expertise and core capabilities in vector optimization, process development, manufacturing, and assay development. For more information, visit the company's website at www.adverum.com.

Aegion (AEGN)

Aegion (NASDAQ: AEGN) maintains, rehabilitates and strengthens infrastructure around the world. Since 1971, the company has played a pioneering role in finding transformational solutions to rehabilitate aging infrastructure, primarily pipelines in the wastewater, water, energy, mining and refining industries. Aegion also maintains the efficient operation of refineries and other industrial facilities and provides innovative solutions for the strengthening of buildings, bridges and other structures. For more information, visit the company's website at www.aegion.com.

Aerie Pharmaceuticals (AERI)

Aerie Pharmaceuticals (NASDAQ: AERI) is a clinical stage pharmaceutical company focusing on the discovery of innovative treatments for glaucoma and other eye ailments. Its leading product candidates, Rhopressa™ and Roclatan™, are believed to be effective for most glaucoma patients, based on clinical trials results, and are currently in different stages of development in view of commercialization. Aerie is also focused on the development of additional product candidates and technologies in ophthalmology. For more information, visit the company's website at www.aeriepharma.com.

Aethlon Medical (AEMD)

Aethlon Medical (NASDAQ: AEMD) develops immunotherapeutic technologies to combat infectious disease and cancer. To augment the body's natural immune defenses, the Aethlon Hemopurifier® eliminates life-threatening disease targets that are often shielded from the immune system and not well addressed by traditional drug therapies. The Hemopurifier® is currently being advanced under an FDA approved clinical study. Aethlon is also the majority owner of Exosome Sciences, Inc., a company focused on the discovery of exosomal biomarkers to diagnose and monitor life-threatening diseases. For more information, visit the company's website at www.aethlonmedical.com.

Agile Therapeutics (AGRX)

Agile Therapeutics (NASDAQ: AGRX) is a specialty pharmaceutical company that focuses on the development and commercialization of prescription contraceptive products for women. Its lead product candidate, Twirla, is a once-weekly contraceptive patch currently in phase III clinical development. The company is also developing a pipeline of other new transdermal contraceptive products, including AG200-ER, a regimen that allows a woman to extend the length of her cycle; AG200-SP, which is a regimen designed to provide shorter lighter periods; and AG890, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. For more information, visit the company's website at www.agiletherapeutics.com.

Akari Therapeutics (AKTX)

Akari Therapeutics (NASDAQ: AKTX) is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of treatments for a range of rare and orphan autoimmune and inflammatory diseases caused by dysregulation of complement component 5 (C5), including paroxysmal nocturnal hemoglobinuria, Guillain Barre syndrome and atypical Hemolytic Uremic Syndrome. Its lead drug, Coversin, a complement inhibitor, acts on complement C5, preventing release of C5a and formation of C5b-9. The company is currently conducting a phase Ib clinical trial of Coversin. For more information, visit the company's website at www.akaritx.com.

Akoustis Technologies (AKTS)

Akoustis Technologies (OTC: AKTS) operates in the telecommunications and fiber optics sector where it designs and manufactures various radio frequency (RF) filters enabling the RF front-end of mobile wireless devices, such as smartphones and tablets. Akoustis focuses on manufacturing and commercializing its patent-pending Bulk ONE acoustic wave technology to address the frequency-selectivity requirements in mobile smartphones, enhancing the efficiency and signal quality of mobile wireless devices and enabling The Internet of Things. For more information, visit the company's website at www.akoustis.com.

Alcobra (ADHD)

Alcobra (NASDAQ: ADHD) is an emerging pharmaceutical company primarily focused on the development and commercialization of medications to treat CNS and cognitive disorders such as ADHD and Fragile X syndrome. The company's objective is to develop and commercialize novel, proprietary pharmaceutical products for treatment of these disorders. For more information, visit the company's website at www.alcobra-pharma.com.

Align Technology (ALGN)

Align Technology (NASDAQ: ALGN) is provider of clear aligner orthodontics that designs, manufactures and markets the Invisalign® system, which provides dental professionals with a range of treatment options for adults and teenagers. Align also offers the iTero 3D digital scanning system and services for orthodontic and restorative dentistry. Align was founded in March 1997 and received FDA clearance to market the Invisalign system in 1998. For more information, visit the company's website at www.aligntech.com.

Alimera (ALIM)

Alimera (NASDAQ: ALIM), founded in June 2003, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. Alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in our aging populations. The company's commitment to retina specialists and their patients is manifest in its product and development portfolio designed to treat early- and late-stage diseases. For more information, visit the company's website at www.alimerasciences.com.

Ameresco (AMRC)

Ameresco (NYSE: AMRC) is an independent provider of comprehensive services, energy efficiency, infrastructure upgrades, asset sustainability and renewable energy solutions for businesses and organizations throughout North America and Europe. The company's sustainability services include upgrades to a facility's energy infrastructure and the development, construction and operation of renewable energy plants. Founded in 2000, Ameresco has completed energy saving, environmentally responsible projects with federal, state and local governments, healthcare and educational institutions, housing authorities, and commercial and industrial customers. With its corporate headquarters in Framingham, MA, Ameresco has more than 1,000 employees in the United States, Canada, and the United Kingdom. For more information, visit the company's website at www.ameresco.com.

American Outdoor Brands (AOBC)

American Outdoor Brands (NASDAQ: AOBC) is a provider of products for shooting, hunting, and rugged outdoor enthusiasts in the global consumer and professional markets. The company reports two segments: Firearms and Outdoor Products & Accessories. Firearms manufactures handgun and long gun products sold under the Smith & Wesson®, M&P®, and Thompson/Center Arms™ brands as well as provides forging, machining, and precision plastic injection molding services. Outdoor Products & Accessories provides shooting, hunting, and outdoor accessories, including reloading, gunsmithing, and gun cleaning supplies, tree saws, vault accessories, knives, laser sighting systems, tactical lighting products, and survival and camping equipment. For more information, visit the company's website at www.aob.com.

American States Water (AWR)

American States Water (NYSE: AWR) is the parent of Golden State Water Company and American States Utility Services, Inc. Through its utility subsidiary, Golden State Water Company, AWR provides water service to approximately 261,000 customers located throughout 10 counties in California. The company also distributes electricity to approximately 24,000 customers in the City of Big Bear and surrounding areas in San Bernardino County, California. Through its contracted services subsidiary, American States Utility Services, Inc., the company provides operations, maintenance and construction management services for water and wastewater systems located on military bases throughout the country under 50-year privatization contracts with the U.S. government. For more information, visit the company's website at www.aswater.com.

American Superconductor (AMSC)

American Superconductor (NASDAQ: AMSC) generates ideas, technologies and solutions to meet the world's demand for smarter, cleaner … better energy™. Through its Windtec™ Solutions, the company provides wind turbine electronic controls and systems, designs and engineering services that reduce the cost of wind energy. Through its Gridtec™ Solutions, the company provides the engineering planning services and advanced grid systems that optimize network reliability, efficiency and performance. The company's solutions are now powering gigawatts of renewable energy globally and are enhancing the performance and reliability of power networks in more than a dozen countries. Founded in 1987, AMSC is headquartered near Boston, Massachusetts with operations in Asia, Australia, Europe and North America. For more information, visit the company's website at www.amsc.com.

American Vanguard (AVD)

American Vanguard (NYSE: AVD) is a diversified specialty and agricultural products company that develops and markets products for crop protection and management, turf and ornamentals management and public and animal health. The company employs a strategy of acquiring or licensing both new and well-established product lines that serve numerous high valued market niches. New product development and international expansion also provide an additional stimulus for growth. The company is included on the Russell 2000® & Russell 3000® Indexes and the Standard & Poors 600 Index. For more information, visit the company's website at www.american-vanguard.com.

AmpliPhi Biosciences (APHB)

AmpliPhi Biosciences (NYSE: APHB) is a biotechnology company focused on the development and commercialization of novel bacteriophage-based antibacterial therapeutics. AmpliPhi's product development programs target infections that are often resistant to existing antibiotic treatments. AmpliPhi has reported final results from two phase 1 clinical trials of AB-SA01, one for the treatment of Staphylococcus aureus (S. aureus) in chronic rhinosinusitis patients and one to evaluate the safety of AB-SA01 when administered topically to the intact skin of healthy adults. AmpliPhi is also developing bacteriophage therapeutics targeting Pseudomonas aeruginosa (P. aeruginosa) and Clostridium difficile (C. difficile) in collaboration with a number of leading organizations focused on the advancement of bacteriophage-based therapies. For more information, visit www.ampliphibio.com.

Amtech Systems (ASYS)

Amtech Systems (NASDAQ: ASYS) is a global supplier of advanced thermal processing equipment to the solar, semiconductor, electronics, and LED manufacturing markets. The company's equipment includes diffusion, ALD and PECVD systems and solder reflow systems. Amtech also supplies wafer handling automation and polishing equipment and related consumable products. The company's wafer handling, thermal processing and consumable products currently address the diffusion, oxidation, and deposition steps used in the fabrication of solar cells, LEDs, semiconductors, MEMS, printed circuit boards, semiconductor packaging, and the polishing of newly sliced sapphire and silicon wafers. Amtech's products are recognized under the leading brand names Tempress Systems™, Bruce Technologies™, PR Hoffman™, R2D Automation™, SoLayTec, and BTU International. For more information, visit the company's website at www.amtechsystems.com.

Amyris (AMRS)

Amyris (NASDAQ: AMRS) is a renewable products company focused on applying its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products. The company is delivering its No Compromise® products across a number of markets, including specialty and performance chemicals, flavors and fragrances, cosmetics ingredients, and pharmaceuticals and nutraceuticals. Amyris first used its proprietary conversion process to produce a lower cost, stable supply of artemisinin, an effective malaria treatment, thereby saving up to 1 million children a year. For more information, visit the company's website at www.amyris.com.

Apollo Endosurgery (APEN)

Apollo Endosurgery (NASDAQ: APEN) is a medical device company focused on less invasive therapies for the treatment of obesity, a condition facing over 500 million people globally, as well as other gastrointestinal disorders. The company's device based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 80 countries today. For more information, visit the company's website at www.apolloendo.com.

Applied Genetic Technologies (AGTC)

Applied Genetic Technologies (NASDAQ: AGTC) is a clinical-stage biotechnology company that uses its proprietary gene therapy platform to develop products designed to transform the lives of patients with severe diseases, with an initial focus in ophthalmology. AGTC's lead product candidates are designed to treat inherited orphan diseases of the eye, caused by mutations in single genes that significantly affect visual function and currently lack effective medical treatments. AGTC's product pipeline includes ophthalmology programs in X-linked retinoschisis (XLRS), X-linked retinitis pigmentosa (XLRP), achromatopsia, wet age-related macular degeneration, and our optogenetics program with Bionic Sight. AGTC's non-ophthalmology programs include its adrenoleukodystrophy program and its otology program, which is in pre-clinical development and the company expects to advance several otology product candidates into clinical development in the next few years. Each of AGTC's XLRS, XLRP and adrenoleukodystrophy programs are partnered with Biogen. Additionally, the company has a significant intellectual property portfolio and extensive expertise in the design of gene therapy products including capsids, promoters and expression cassettes, as well as, expertise in the formulation, manufacture and physical delivery of gene therapy products. For more information, visit the company's website at www.agtc.com.

Aptevo Therapeutics (APVO)

Aptevo Therapeutics (NASDAQ: APVO) is a biotechnology company based in Seattle, Washington focused on novel oncology and hematology therapeutics to meaningfully improve patients' lives. The company's core technology is the ADAPTIR™ (modular protein technology) platform. Aptevo has four commercial products in the areas of hematology and infectious diseases, as well as various investigational stage product candidates in immuno-oncology. For more information, visit the company's website at www.aptevotherapeutics.com.

Aptose Biosciences (APTO)

Aptose Biosciences (NASDAQ: APTO) is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. Aptose is advancing new therapeutics focused on novel cellular targets on the leading edge of cancer research coupled with companion diagnostics to identify the optimal patient population for its products. The company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities. For more information, visit the company's website at www.aptose.com.

Aqua Metals (AQMS)

Aqua Metals (NASDAQ: AQMS) is engaged in reinventing lead recycling with its patent-pending AquaRefiningTM technology. Unlike smelting, AquaRefining is a room temperature, water-based process that is fundamentally non-polluting. Aqua Metals expects its modular AquaRefining systems to allow the lead-acid battery industry to simultaneously reduce negative environmental impacts and increase production to meet rapidly growing demand. Aqua Metals is based in Alameda, California and built its first recycling facility in Nevada's Tahoe-Reno Industrial Center. For more information, visit the company's website at www.aquametals.com.

Arch Therapeutics (ARTH)

Arch Therapeutics (OTCQB: ARTH) is a biotech company developing an innovative, elegant and superior approach to the rapid cessation of bleeding (hemostasis) and control of fluid leakage (sealant) during surgery and trauma care. The underlying technology, exclusively licensed from a leading university, supports an innovative platform of smart materials that fulfill the criteria as a solution for a specialized field we call, "stasis and barrier applications." For more information, visit the company's website at www.archtherapeutics.com.

ARI Network Services (ARIS)

ARI Network Services (NASDAQ: ARIS) ("ARI") offers a suite of SaaS, software tools, and marketing services to help dealers, equipment manufacturers and distributors in selected vertical markets Sell More Stuff!™ -- online and in-store. The company's innovative products are powered by a proprietary data repository of enriched original equipment and aftermarket electronic content spanning more than 17 million active part and accessory SKUs and 750,000 equipment models. ARI removes the complexity of selling and servicing new and used vehicle inventory, parts, garments and accessories for customers in the automotive tire and wheel aftermarket, power-sports, outdoor power equipment, marine, home medical equipment, recreational vehicles and appliance industries. For more information, visit the company's website at investor.arinet.com.

Aspen Group (ASPU)

Aspen Group (OTC: ASPU) is a workforce management and solutions company which provides facilities management/outsourcing, staff augmentation, project management, and consulting services. The company was the result of a careful analysis of the staffing industry and the identification of a range of unmet needs relative to quality of screening processes and commitment to customer service. Utilizing a mission of service excellence and a goal of accommodating and cooperating with existing staffing firms, Aspen is a one-stop business services center that provides a wide range of employment arrangements and specialized career services throughout the U.S. and abroad. For more information, visit the company's website at www.theaspengroupinc.com.

Asure Software (ASUR)

Asure Software (NASDAQ: ASUR), headquartered in Austin, Texas, offers intuitive and innovative technologies that enable companies of all sizes and complexities to operate more efficiently. The company ensures a high-performing work environment by integrating its "keep it simple" solutions and expertise to more than 7,000 clients worldwide. Asure Software's suite of solutions range from HCM workforce management solutions, time and attendance to workspace asset optimization and meeting room management solutions. For more information, visit the company's website at www.asuresoftware.com.

ATN International (ATNI)

ATN International (NASDAQ: ATNI), headquartered in Beverly, Massachusetts, provides telecommunications services to rural, niche and other under-served markets and geographies in the United States, Bermuda and the Caribbean and owns and operates solar power systems in select locations in the United States and India. Through its operating subsidiaries, the company provides both wireless and wireline connectivity to residential and business customers, including a range of mobile wireless solutions, local exchange services and broadband internet services as well as distributed solar electric power to corporate, utility and municipal customers. Additionally, ATN is the owner and operator of terrestrial and submarine fiber optic transport systems. For more information, visit the company's website at www.atni.com.

Attunity (ATTU)

Attunity (NASDAQ: ATTU) provides data integration and big data management software solutions that enable availability, delivery, and, management of data across heterogeneous enterprise platforms, organizations, and the cloud. The company's software solutions include data replication and distribution, test data management, change data capture, data connectivity, enterprise file replication, managed file transfer, data warehouse automation, data usage analytics, and cloud data delivery. Headquartered in Boston, Attunity serves its customers via offices in North America, Europe, and Asia Pacific and through a network of local partners. For more information, visit the company's website at www.attunity.com.

Auris Medical (EARS)

Auris Medical (NASDAQ: EARS) is a Swiss biopharmaceutical company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology. The company is focused on the phase 3 development of treatments for acute inner ear hearing loss (AM-111) and for acute inner ear tinnitus (Keyzilen®; AM-101) by way of intratympanic administration with biocompatible gel formulations. In addition, Auris Medical is pursuing intranasal betahistine for Meniere's disease and vestibular vertigo (AM-125) and early-stage research and development projects. The company was founded in 2003 and is headquartered in Zug, Switzerland. For more information, visit the company's website at www.aurismedical.com.

Auxilio (AUXO)

Auxilio (OTCQB: AUXO) provides complete document workflow solutions and IT security services to healthcare organizations across the United States. The company has helped its clients save more than $80 million since 2004 by providing solutions which lower costs, improve operational efficiency and enhance security. Auxilio's iPLATFORM, an intelligent workflow automation suite delivers a customer driven, vendor neutral approach to secure patient health information, reduce waste and drive additional savings opportunities. Auxilio serves a national portfolio of nearly 220 hospital campuses and manages over 1.5 billion documents annually from over 90,000 devices supporting over 280,000 caregivers. For more information, visit the company's website at www.auxilioinc.com.

Avadel Pharmaceuticals (AVDL)

Avadel Pharmaceuticals (NASDAQ: AVDL) is a specialty pharmaceutical company that seeks to develop differentiated pharmaceutical products that are safe, effective and easy to develop. The company utilizes its proprietary drug delivery technology and in-licensing or acquiring new products to ultimately help patients see better results. Avadel currently markets products in the hospital and primary care spaces. The company is headquartered in Dublin, Ireland with operations in St. Louis, Missouri and Lyon, France. For more information, visit the company's website at www.avadel.com.

AVEO Oncology (AVEO)

AVEO Oncology (NASDAQ: AVEO) is a biopharmaceutical company dedicated to advancing a broad portfolio of targeted therapeutics for oncology and other areas of unmet medical need. The company is focused on developing and commercializing its lead candidate tivozanib in North America as a treatment for Renal Cell Carcinoma and other cancers. AVEO is leveraging multiple partnerships to develop and commercialize tivozanib in non-oncologic indications worldwide and oncology indications outside of North America, as well as to progress its pipeline of novel therapeutic candidates in cancer and cachexia. For more information, visit the company's website at www.aveooncology.com.

Aviat Networks (AVNW)

Aviat Networks (NASDAQ: AVNW) provides a comprehensive suite of localized professional and support services enabling customers to drastically simplify both their networks and their lives. With more than one million systems sold into 170 countries worldwide, communications service providers and private network operators including state and local government, utility, federal government and defense organizations trust Aviat with their critical applications. Aviat Networks is headquartered in Milpitas, California. For more information, visit the company's website at www.aviatnetworks.com.

Avino Silver & Gold Mines (ASM)

Avino Silver & Gold Mines (NYSE: ASM) is engaged in the production and sale of silver, gold and copper bulk concentrates, as well as in the exploration, evaluation and acquisition of mineral properties. The company owns 42 mineral claims and leases four mineral claims in the state of Durango, Mexico. It also holds 100% interests in the Bralorne mine located in the Lillooet mining division, British Columbia, Canada; and the Eagle property located in the Mayo mining division of Yukon, Canada. Avino Silver & Gold Mines Ltd. was founded in 1968 and is headquartered in Vancouver, Canada. For more information, visit the company's website at www.avino.com.

AxoGen (AXGN)

AxoGen (NASDAQ: AXGN) is engaged in innovative surgical solutions for peripheral nerve injuries. AxoGen's portfolio of products includes Avance®Nerve Graft, AxoGuard® Nerve Connector, AxoGuard® Nerve Protector, and Avive™ Soft Tissue Membrane. Along with these core surgical products, the company also offers AxoTouch™ Two-Point Discriminator and AcroVal™ Neurosensory & Motor Testing System. These evaluation and measurement tools assist health care professionals in detecting changes in sensation, assessing return of sensory, grip, and pinch function, evaluating effective treatment interventions, and providing feedback to patients on nerve function. The AxoGen portfolio of products is available in the United States, Canada, the United Kingdom, and several European and international countries. For more information, visit the company's website at www.axogeninc.com.

Azure Power Global (AZRE)

Azure Power Global (NYSE: AZRE) is an independent power producer. The company developed India's first private utility scale solar project in 2009 and has been a developer, constructor and operator of utility scale, micro-grid and rooftop solar projects since its inception in 2008. With its in-house engineering, procurement and construction expertise and advanced in-house operations and maintenance capability, Azure Power manages the entire development and operation process, providing low-cost solar power solutions to customers throughout India. For more information, visit the company's website at www.azurepower.com.

Ballard Power Systems (BLDP)

Ballard Power Systems (NASDAQ: BLDP) is engaged in the development and commercialization of proton exchange membrane fuel cells worldwide. The company is primarily involved in the design, development, manufacture, sale and service of fuel cell stacks, modules and systems for various applications. Ballard also develops methanol clean energy backup power systems, as well as provides engineering services for various fuel cell applications including portable power, material handling, and telecom backup power, as well as power product markets of bus and tram applications. For more information, visit the company's website at www.ballard.com.

Barfresh Food Group (BRFH)

Barfresh Food Group (OTC: BRFH) is a developer, manufacturer and distributor of ready-to-blend beverages, including smoothies, shakes and frappes, primarily for restaurant chains and the foodservice industry. The company's proprietary, patented system uses portion-controlled pre-packaged beverage ingredients that deliver freshly made frozen beverages without waste that are quick and cost efficient. PepsiCo North America Beverages, a division of PepsiCo, Inc., is the exclusive sales representative in North America within the food service channel for Barfresh's full line of beverages. For more information, visit the company's website at www.barfresh.com.

Barrett Business Services (BBSI)

Barrett Business Services (NASDAQ: BBSI) is a provider of business management solutions, combining human resource outsourcing and professional management consulting to create a unique operational platform that differentiates it from competitors. The company's integrated platform is built upon expertise in payroll processing, employee benefits, workers' compensation coverage, risk management and workplace safety programs, and human resource administration. BBSI's partnerships help businesses of all sizes improve the efficiency of their operations. The company works with more than 4,500 clients across all lines of business in 23 states. For more information, visit the company's website at www.barrettbusiness.com.

Bel Fuse (BELFB)

Bel Fuse (NASDAQ: BELFB) designs, manufactures, markets and sells products used in the networking, telecommunication, high-speed data transmission, commercial aerospace, military, broadcasting, transportation and consumer electronic industries worldwide. It offers magnetic products, such as integrated connector modules; power transformers; SMD power inductors and SMPS transformers; and telecom discrete components. The company also provides power solutions and protection products comprising front-end power supplies. For more information, visit the company's website at www.belfuse.com.

BG Staffing (BGSF)

BG Staffing (NYSE: BGSF) is a multi-division, publicly traded workforce solutions firm that operates through three segments: multifamily, professional, and commercial. The commercial segment provides temporary workers for various skilled and unskilled positions primarily to distribution, logistics, and call center customers. The multifamily segment offers front office and maintenance personnel to the multifamily housing industry on a temporary basis. The professional segment provides skilled temporary workers for IT customer projects, and finance and accounting needs. This segment also offers finance, accounting, and related support personnel. For more information, visit the company's website at www.bgstaffing.com.

BioAmber (BIOA)

BioAmber (NYSE: BIOA) is a renewable materials company. Its innovative technology platform combines biotechnology and catalysis to convert renewable feedstock into building block materials that are used in a wide variety of everyday products including plastics, paints, textiles, food additives and personal care products. For more information, visit the company's website at www.bio-amber.com.

Biocept (BIOC)

Biocept (NASDAQ: BIOC) is a cancer diagnostics company that develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. The company's cancer assays provide information to oncologists and other physicians that enable them to select personalized treatment for their patients based on detailed data on the characteristics of tumors. It offers assays for solid tumor indications, such as breast cancer, lung cancer, gastric cancer, colorectal cancer, prostate cancer and melanoma. For more information, visit the company's website at www.biocept.com.

BioDelivery Sciences International (BDSI)

BioDelivery Sciences International (NASDAQ: BDSI) is a specialty pharmaceutical company with a focus in the areas of pain management and addiction medicine. The company uses its novel and proprietary BioErodible MucoAdhesive (BEMA®) technology and other drug delivery technologies to develop and commercialize, either on its own or in partnership with third parties, new applications of proven therapies aimed at addressing important unmet medical needs. The company's development strategy focuses on the utilization of the FDA's 505(b)(2) approval process which creates the potential for more timely and efficient approval of new formulations of previously approved therapeutics. BDSI's marketed products and those in development address serious and debilitating conditions such as breakthrough cancer pain, chronic pain, painful diabetic neuropathy and opioid dependence. BDSI's headquarters is in Raleigh, North Carolina. For more information, visit the company's website at www.bdsi.com.


BIOLASE (NASDAQ: BIOL) is a medical device company that develops, manufactures and markets laser systems in dentistry and medicine in the United States and internationally. It offers Waterlase dental laser systems for cutting soft and hard tissue; and diode laser systems, which are used in soft tissue, pain therapy, and cosmetic procedures, such as teeth whitening. The company's dental laser systems allow dentists, periodontists, endodontists, oral surgeons and other dental specialists to perform a range of dental procedures, including cosmetic, restorative, and complex surgical applications. For more information, visit the company's website at www.biolase.com.

BioLineRx (BLRX)

BioLineRx (NASDAQ: BLRX) a clinical-stage biopharmaceutical development company that engages in identifying, in-licensing and developing therapeutic candidates that address unmet medical needs. Its development pipeline consists of three primary clinical-stage therapeutic candidates: BL-8040, a novel peptide for the treatment of multiple cancer and hematological indications; BL-7010, a novel co-polymer for the treatment of celiac disease and gluten sensitivity; and BL-5010, a customized, proprietary, pen-like applicator containing a novel, acidic, aqueous solution as a medical device for the non-surgical removal of benign skin lesions. For more information, visit the company's website at www.biolinerx.com.

Biomerica (BMRA)

Biomerica (NASDAQ: BMRA) is a global biomedical company that develops, manufactures and markets advanced diagnostic products used at the point-of-care (in home and in physicians' offices) and in hospital/clinical laboratories for the early detection of medical conditions and diseases. The company's products are designed to enhance health and well-being, while reducing total healthcare costs. Biomerica primarily focuses on products for gastrointestinal disease, diabetes, and esoteric testing. For more information, visit the company's website at www.biomerica.com.

Bionomics (BNOEF)

Bionomics (OTC: BNOEF) is a global, clinical stage biopharmaceutical company leveraging its proprietary platform technologies to discover and develop a deep pipeline of novel drug candidates. The company focuses on the treatment of serious central nervous system disorders and on the treatment of cancer. Bionomics' lead drug candidate BNC210, currently in phase 2 for the treatment of generalized anxiety disorder and for post-traumatic stress disorder, is a novel, proprietary negative allosteric modulator of the alpha-7 (α7) nicotinic acetylcholine receptor. The company is also developing BNC101, its lead humanized monoclonal antibody targeting a key receptor on cancer stem cells that is overexpressed in metastatic colorectal cancer, metastatic pancreatic cancer and many other solid tumours; BNC101 entered clinical trials in the first quarter of 2016. Bionomics has strategic partnerships with Merck & Co., Inc. in pain and cognition. For more information, visit the company's website at www.bionomics.com.au.

BioPharmX (BPMX)

BioPharmX (NYSE: BPMX) is a Silicon Valley-based specialty pharmaceutical company that seeks to provide products through proprietary platform technologies for prescription, over-the-counter and supplement applications in dermatology, aesthetics and women's health. The company's product pipeline includes Violet®, the company's initial direct-to-consumer product; BPX-01, currently in phase 2 of clinical development; and BPX-03, currently in phase 3 with regulatory filings in progress. For more information, visit the company's website at www.BioPharmX.com.

BioSig Technologies (BSGM)

BioSig Technologies (OTC: BSGM) is a development-stage medical device company that engages in developing a technology platform to minimize noise and artifacts from cardiac recordings during electrophysiology studies and ablation. Its products under development include PURE (Precise Uninterrupted Real-time evaluation of Electrograms) EP system, a surface electrocardiogram and intracardiac multichannel recording and analysis system that acquires, processes, and displays electrocardiogram and electrograms required during electrophysiology studies and ablation procedures. For more information, visit the company's website at www.biosigtech.com.

BioSpecifics Technologies (BSTC)

BioSpecifics Technologies (NASDAQ: BSTC) is a biopharmaceutical company that engages in the development of an injectable collagenase clostridium histolyticum for multiple indications in the United States. The company offers injectable collagenase for the treatment of Dupuytren's contracture and Peyronie's disease under the XIAFLEX brand in Canada and Australia, as well as under XIAPEX brand name in Europe. It also provides injectable collagenase to treat frozen shoulder, cellulite, canine lipoma, lateral hip fat, and plantar fibromatosis, as well as for the treatment of human lipoma and uterine fibroids. BioSpecifics is also involved in the development of other clinical indications for which collagenase injection has been tested. For more information, visit the company's website at www.biospecifics.com.

Blue Bird (BLBD)

Blue Bird (NASDAQ: BLBD) is an independent designer and manufacturer of school buses, with more than 550,000 buses sold since its formation in 1927 and approximately 180,000 buses in operation today. Blue Bird focuses on the design, engineering, manufacture and sale of school buses and related parts. The company is the only manufacturer of chassis and body production specifically designed for school bus applications, and offers alternative fuel applications with its propane-powered and compressed natural gas-powered school buses. Blue Bird manufactures school buses at two facilities in Fort Valley, Georgia. Its Micro Bird joint venture operates a manufacturing facility in Drummondville, Quebec, Canada. Service and after-market parts are distributed from Blue Bird's parts distribution center located in Delaware, Ohio. For more information, visit the company's website at www.blue-bird.com.

BNK Petroleum (BNKPF)

BNK Petroleum (OTC: BNKPF) is an international oil and gas exploration and production company focused on finding and exploiting large, predominately unconventional oil and gas resource plays. Through various affiliates and subsidiaries, the company owns and operates shale oil and gas properties and concessions in the United States and Spain. Additionally, the company is utilizing its technical and operational expertise to identify and acquire additional unconventional projects. For more information, visit the company's website at www.bnkpetroleum.com.

Bovie Medical (BVX)

Bovie Medical (NYSE: BVX) is a provider of medical devices and supplies as well as the developer of J-Plasma®, a patented new plasma-based surgical product for cutting and coagulation. J-Plasma® utilizes a helium ionization process to produce a stable, focused beam of ionized gas that provides surgeons with greater precision, minimal invasiveness and an absence of conductive currents through the patient during surgery. Bovie is also engaged in the manufacture of a range of electrosurgical products and technologies, marketed through both private labels and the company's own brands (Bovie®, Aaron®, IDS™ and ICON™) to distributors worldwide. The company also leverages its expertise through original equipment manufacturing (OEM) agreements with other medical device manufacturers. For more information, visit the company's website at www.boviemed.com.

Broadwind Energy (BWEN)

Broadwind Energy (NASDAQ: BWEN) provides components and gearing as well as other specialized applications for customers in the clean tech, energy and infrastructure markets. The company is a precision manufacturer of these structures, equipment and components. With facilities throughout the U.S., the company is committed to helping customers maximize performance of their investments in a quicker, easier and smarter way. For more information, visit the company's website at www.bwen.com.

Cachet Financial Solutions (CAFN)

Cachet Financial Solutions (OTC: CAFN) is a cloud-based, SaaS technology provider serving the financial services industry with mobile money and remote deposit capture solutions for PC, Mac and mobile devices. Founded in early 2010, the company has since shown remarkable growth, an impressive client base and award-winning technology. The company's solutions help clients to increase customer engagement, grow revenues and gain competitive advantage. Cachet's cloud-based technology platform simplifies development, deployment and servicing of consumer and commercial solutions—minimizing cost and accelerating speed-to-market and ROI. For more information, visit the company's website at www.cachetfinancial.com.

CadiZ (CDZI)

CadiZ (NASDAQ: CDZI) is a renewable resources company that owns 70 square miles of property with significant water resources in Southern California. Founded in 1983, the company maintains an organic agricultural development in the Cadiz Valley of eastern San Bernardino County, California and is partnering with public water agencies to implement the Cadiz Water Project. The company abides by a wide-ranging "Green Compact" focused on environmental conservation and sustainable practices to manage its land, water and agricultural resources. For more information, visit the company's website at www.cadizinc.com.

Caladrius Biosciences (CLBS)

Caladrius Biosciences (NASDAQ: CLBS) is advancing a proprietary platform technology for immunomodulation by pioneering the use of T regulatory cells as an innovative therapy for recent onset type 1 diabetes. The company's product candidate, CLBS03, is the subject of an ongoing phase 2 clinical trial in collaboration with Sanford Research, and has been granted Orphan Drug and Fast Track designation by the FDA and Advanced Therapeutic Medicinal Product classification by the European Medicines Agency. The company's PCT subsidiary is a development and manufacturing partner to the cell therapy industry. For more information, visit the company's website at www.caladrius.com.

Calgon Carbon (CCC)

Calgon Carbon (NYSE: CCC) provides innovative solutions, high quality products and reliable services designed to protect human health and the environment from harmful contaminants in water and air. As a manufacturer of activated carbon with broad capabilities in ultraviolet light disinfection, the company provides purification solutions for drinking water, wastewater, pollution abatement, and a variety of industrial and commercial manufacturing processes. Headquartered in Pittsburgh, Pennsylvania, the company operates 22 manufacturing, reactivation, innovation and equipment fabrication facilities in the U.S., Asia, and Europe. For more information, visit the company's website at www.calgoncarbon.com.

Callaway Golf (ELY)

Callaway Golf (NYSE: ELY), together with its subsidiaries, creates innovative products designed to make every golfer a better golfer. It offers drivers, fairway woods, hybrids, irons, wedges, and putters. The company also designs and sells golf accessories, such as packaged sets, golf bags, golf gloves, golf footwear, golf apparel, travel gear, headwear, towels, umbrellas, eyewear, and other accessories under the Callaway Golf®, Odyssey®, and OGIO brand names. In addition, it licenses its trademarks and service marks for use on golf related accessories, such as golf apparel and footwear, golf gloves, prescription eyewear, and practice aids. The company sells its products directly to golf retailers, sporting goods retailers, and mass merchants; and to third-party distributors in the United States, as well as in approximately 100 countries. For more information, visit the company's website at www.callawaygolf.com.

Callidus Software (CALD)

Callidus Software (NASDAQ: CALD) is engaged in cloud-based sales, marketing, learning and customer experience solutions. CallidusCloud® enables organizations to accelerate and maximize their lead to money process with a complete suite of solutions that identify the right leads, ensure proper territory and quota distribution, enable sales forces, automate configure price quote, and streamline sales compensation – driving bigger deals, faster. Over 5,200 leading organizations, across all industries, rely on CallidusCloud to optimize the lead to money process to close more deals for more money in record time. For more information, visit the company's website at www.calliduscloud.com.

Camber Energy (CEI)

Camber Energy (NYSE: CEI), formally Lucas Energy, Inc., engages in the exploitation, development, and production of crude oil, natural gas, and natural gas liquids in the United States. Based in Houston, Texas, Camber is a growth-oriented, independent oil and gas company engaged in the development of crude oil and natural gas in the Austin Chalk and Eagle Ford formations in south Texas, the Permian Basin in west Texas, and the Hunton formation in central Oklahoma. For more information, visit the company's website at www.camber.energy.

Capricor Therapeutics (CAPR)

Capricor Therapeutics (NASDAQ: CAPR) is a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other medical conditions. The company's lead candidate, CAP-1002, is a cardiac cell therapy that is currently being evaluated for the treatment of heart disease associated with Duchenne muscular dystrophy and myocardial infarction (heart attack). Capricor is exploring the use of CAP-2003, its exosome product candidate in various therapeutic areas including the treatment of ophthalmic disorders. For more information, visit the company's website at www.capricor.com.

Capstone Companies (CAPC)

Capstone Companies (OTC: CAPC) designs, manufactures and sells power failure lighting solutions and other consumer products in North America and internationally. Its consumer lighting products include power failure multi-function handheld and night lights, wall-plates, decorative nightlights, wireless motion sensor lights, remote control battery powered accent lights, and remote control outlets. The company markets and sells its products under the CAPI and Capstone Lighting brand names through independent sales force, distributors and wholesalers who focus on mass merchandisers, warehouse clubs, department stores, and hardware centers, as well as food, drug and convenience stores. For more information, visit the company's website at www.capstonecompaniesinc.com.

Capstone Turbine (CPST)

Capstone Turbine (NASDAQ: CPST) develops, manufactures, markets and services microturbine technology solutions for use in stationary distributed power generation applications worldwide. The company offers microturbine units, subassemblies, components and various accessories for applications, including cogeneration comprising combined heat and power (CHP) and integrated CHP, as well as combined cooling, heat and power; and renewable energy, natural resources, and critical power supply. Its microturbines are also used as battery charging generators for hybrid electric vehicle applications. For more information, visit the company website at www.capstoneturbine.com.

CAS Medical Systems (CASM)

CAS Medical Systems (NASDAQ: CASM) is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products. The vompany's FORE-SIGHT® Cerebral Oximeters provide a highly accurate, non-invasive measurement of tissue oxygenation in the brain. Direct monitoring of tissue oxygenation can provide a superior and powerful tool to alert clinicians to otherwise unrecognized and dangerously low levels of oxygen in the brain and empower them to improve patient care. CAS Medical also provides proprietary non-invasive blood pressure monitoring solutions for OEM use and neonatal intensive care supplies. For more information, visit the company's website at www.corporate.casmed.com.

Castle Brands (ROX)

Castle Brands (NYSE: ROX) develops, markets, imports, and sells beverage alcohol products in the United States and internationally. Its product categories include rum, whiskey, liqueurs, vodka, tequila, wine, and other spirits, as well as ginger beer and ready-to-drink cocktails. The company offers its products under the Jefferson's®, Goslings® Rums, Knappogue Castle Whiskey®, Clontarf® Irish Whiskey, Pallini® Limoncello, Boru® Vodka, Brady's® Irish Cream, The Arran Malt® Single Malt Scotch Whisky, The Robert Burns Scotch Whisky and Machrie Moor Scotch Whisky brands through a network of wholesale distributors and state-operated agencies. Castle Brands was incorporated in 2009 and is based in New York, New York. For more information, visit the company's website at www.castlebrandsinc.com.

Catalyst Pharmaceuticals (CPRX)

Catalyst Pharmaceuticals (NASDAQ: CPRX) is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases, including Lambert-Eaton myasthenic syndrome (LEMS), congenital myasthenic syndromes (CMS), infantile spasms, and Tourette's Disorder. Firdapse® for the treatment of LEMS has received Breakthrough Therapy Designation from the FDA and orphan drug designation for LEMS, CMS and myasthenia gravis. CPP-115 has been granted U.S. orphan drug designation for the treatment of infantile spasms by the FDA and has been granted E.U. orphan medicinal product designation for the treatment of West Syndrome by the European Commission. For more information, visit the company's website at www.CatalystPharma.com.

Catasys (CATS)

Catasys (OTC: CATS) provides big data based analytics and predictive modeling driven behavioral healthcare services to health plans and their members through its OnTrak solution. The company's OnTrak solution is designed to improve member health and lower costs to the insurer for underserved populations where behavioral health conditions cause or exacerbate co-existing medical conditions. The solution utilizes proprietary analytics and proprietary enrollment, engagement and behavioral modification capabilities to assist members who otherwise do not seek care through a patient-centric treatment that integrates evidence-based medical and psychosocial interventions along with care coaching in a 52-week outpatient treatment solution. For more information, visit the company's website at www.catasys.com.

Cavium (CAVM)

Cavium (NASDAQ: CAVM) designs, develops, and markets semiconductor processors for intelligent and secure networks in the United States and internationally. It offers integrated semiconductor processors for wired and wireless networking, communications, storage, cloud, wireless, security, video, and connected home and office applications. The company's products also include a suite of embedded security protocols that enable unified threat management, secure connectivity, network perimeter protection, and deep packet inspection. In addition, it provides commercial grade embedded Linux operating systems, development tools, application software stacks, and support and services. Cavium is headquartered in San Jose, CA with design centers in California, Massachusetts, India, China and Taiwan. For more information, visit the company's website at www.cavium.com.

CECO Environmental (CECE)

CECO Environmental (NASDAQ: CECE) ("CECO") is a global provider of engineered technologies and solutions to the energy, environmental, and industrial segments, targeting specific niche-focused end markets through an attractive asset-light business model, strategically balanced across the world. CECO targets its $5 billion+ of installed base, specifically to expand and grow a higher recurring revenue of aftermarket products and services. The company's brands, technologies and solutions have been evolving for well over 50 years to become leading-edge technologies in specific niche global end markets, including natural gas turbine power, refinery & petrochemical engineered cyclones and mid-stream energy pipeline gas transmission. For more information, visit the company's website at www.cecoenviro.com.

Cellectar Biosciences (CLRB)

Cellectar Biosciences (NASDAQ: CLRB) is engaged in the development of targeted phospholipid drug conjugates (PDCs) for the treatment and imaging of cancer. It offers CLR 131, a PDC radiotherapeutic product candidate currently being evaluated in a phase I study for the treatment of relapse or refractory multiple myeloma; CLR 125, a cancer-targeting radiotherapeutic is under pre-clinical investigation for the treatment of micrometastatic disease ; CLR 124, a cancer-targeting positron emission tomography (PET) imaging PDC for the selective detection of tumors and metastases in a broad range of cancers; and CLR 1502, a cancer-targeting NIR-fluorophore optical imaging PDC for intraoperative tumor and tumor margin illumination. For more information, visit the company's website at www.cellectar.com.

Cellectis (CLLS)

Cellectis (NASDAQ: CLLS) is a biopharmaceutical company focused on developing immunotherapies based on gene-edited CAR T-cells (UCART). The company is engaged in developing a new generation of cancer therapies based on engineered T-cells. Cellectis capitalizes on its 17 years of experience in genome engineering based on its flagship TALEN® products and meganucleases as well as its pioneering electroporation PulseAgile technology, to create a new generation of immunotherapies. Using its life-science-focused, pioneering genome-engineering technologies, Cellectis' goal is to create innovative products in multiple fields and with various target markets. For more information, visit the company's website at www.cellectis.com.

Cempra (CEMP)

Cempra (NASDAQ: CEMP) is a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases. Cempra's two lead product candidates are currently in advanced clinical development. Solithromycin has been evaluated in two phase 3 clinical trials for community-acquired bacterial pneumonia. Cempra is currently seeking approval for both intravenous and oral capsule formulations from the U.S. Food and Drug Administration and the European Medicines Agency. Solithromycin is also in a phase 3 clinical trial for uncomplicated urogenital urethritis caused by Neisseria gonorrhoeae or chlamydia. The company's second product candidate, Fusidic acid, has completed enrollment of an initial phase 3 trial comparing fusidic acid to linezolid in patients with acute bacterial skin and skin structure infections. Cempra was founded in 2006 and is headquartered in Chapel Hill, N.C. For more information, visit the company's website at www.cempra.com.

Cemtrex (CETX)

Cemtrex (NASDAQ: CETX) is a diversified industrial and manufacturing company that provides a wide array of solutions to meet today's technology challenges. Cemtrex provides manufacturing services of advanced custom engineered electronics, industrial services, monitoring instruments for industrial processes and environmental compliance, and systems for controlling particulates, hazardous gases, emissions of Greenhouse gases, and other regulated pollutants used in emissions trading globally. For more information, visit the company's website at www.cemtrex.com.


CEVA (NASDAQ: CEVA) licenses signal processing intellectual property (IP) technologies. The company partners with semiconductor companies and OEMs worldwide to create power-efficient, intelligent and connected devices for a range of end markets including mobile, consumer, automotive, industrial and IoT. CEVA's ultra-low-power IPs for vision, audio, communications and connectivity include comprehensive DSP-based platforms for LTE/LTE-A/5G baseband processing in handsets, infrastructure and machine-to-machine devices, advanced imaging, computer vision and deep learning for any camera-enabled device, audio/voice/speech and ultra-low power always-on/sensing applications for multiple IoT markets. CEVA also offers the industry's most widely adopted IPs for bluetooth, Wi-Fi and serial storage. For more information, visit the company's website at www.ceva-dsp.com.

Charles & Colvard (CTHR)

Charles & Colvard (NASDAQ: CTHR) is the original creator of Forever Classic™, Forever Brilliant® and Forever One™ moissanite gemstones for fine jewelry. Moissanite is unique, available in three color grades (colorless, near-colorless and faint color) and produced from silicon carbide (SiC) crystals. Charles & Colvard Created Moissanite® is sold with a Certificate of Authenticity and Limited Lifetime Warranty to wholesale distributors, manufacturers, retailers, TV shopping networks and designers as loose stones or set in a wide variety of quality metal setting options. Charles & Colvard, Ltd. also sells direct to consumers through its wholly owned operating subsidiary, charlesandcolvard.com, LLC, and through third-party marketplaces. For more information, visit the company's website at www.charlesandcolvard.com.

Check-Cap (CHEK)

Check-Cap (NASDAQ: CHEK) is a clinical-stage medical diagnostics company developing the world's first ingestible capsule system for preparation-free, less-invasive colorectal cancer screening. The capsule utilizes innovative ultra-low dose X-ray and wireless communication technologies to scan the inside of the colon as it moves naturally, while the patient follows his or her normal daily routine. After passage, the system generates a 3D map of the inner surface of the colon which enables detection of polyps and cancer. Designed to increase the willingness of individuals to participate in recommended colorectal cancer screening, the Check-Cap system addresses many frequently cited barriers, including laxative bowel preparation, invasiveness, and sedation. The Check-Cap system is currently not cleared for marketing in any jurisdiction. For more information, visit the company's website at www.check-cap.com.

Checkpoint Therapeutics (CKPT)

Checkpoint Therapeutics (OTCQX: CKPT) is an immuno-oncology biopharmaceutical company focused on the acquisition, development, and commercialization of non-chemotherapy and immune-enhanced combination treatments for patients with solid tumor cancers. The company develops a portfolio of human immuno-oncology targeted antibodies. Its products pipeline includes Anti-PD-L1, a preclinical human antagonistic antibody designed to bind to PD-L1 and block its interaction with programmed cell death protein 1; and Anti-GITR, a human agonistic antibody that binds and triggers signaling in glucocorticoid-induced TNFR related protein expressing cells. The company is also developing CK-101, an oral covalent inhibitor, which is in preclinical stage for the treatment of lung cancer; CK-102 that is in phase Ib clinical trial for the treatment of multiple forms of cancer; and Anti-CAIX, which is preclinical trial for the treatment of renal cell carcinoma. It has a collaboration agreement with TG Therapeutics, Inc. to develop and commercialize the Anti-PD-L1 and Anti-GITR antibody research programs in the field of hematological malignancies. For more information, visit the company's website at www.checkpointtx.com.

Cherokee (CHKE)

Cherokee (NASDAQ: CHKE), based in California, markets, manages, and licenses fashion and lifestyle brands for apparel, footwear, home products, and accessories worldwide. The company owns or represents Cherokee, Liz Lange, Completely Me by Liz Lange, Hawk, Tony Hawk, Everyday California, Flip Flop Shops, Sideout, Sideout Sport, Carole Little, Saint Tropez-West, Chorus Line, All That Jazz, and other brands. The company currently maintains license and franchise agreements with leading retailers and manufacturers that span over 110 countries in 12,000 retail locations and digital commerce. For more information, visit the company's website www.cherokeeglobalbrands.com.

Clean Diesel Technologies (CDTI)

Clean Diesel Technologies (NASDAQ: CDTI) develops advanced materials technology for the emissions control market. The company's proprietary technologies provide sustainable solutions to reduce hazardous emissions, increase energy efficiency and lower the carbon intensity of on- and off-road combustion engine systems. With a continuing focus on innovation-driven commercialization and global expansion, CDTi's Powder-to-Coat (P2C™) technology exploits the company's high-performance, advanced low-platinum group metal emission reduction catalysts. Key technology platforms include Mixed Phase Catalyst (MPC®), Base Metal Activated Rhodium Support (BMARS™), Synergized PGM (SPGM™), Zero PGM (ZPGM™) and Spinel™. For more information, visit the company's website www.cdti.com.

Clearfield, Inc. (CLFD)

Clearfield, Inc. (NASDAQ: CLFD) designs, manufactures and distributes fiber optic management, protection and delivery products for communications networks. The company's "fiber to the anywhere" platform serves the unique requirements of leading incumbent local exchange carriers, competitive local exchange carriers, wireless operators, and cable TV companies, while also catering to the broadband needs of the utility/municipality, enterprise, data center and military markets. Headquartered in Minneapolis, MN, Clearfield deploys more than a million fiber ports each year. For more information, visit the company's website www.SeeClearfield.com.

Coeur Mining (CDE)

Coeur Mining (NYSE: CDE) is a diversified precious metals producer with five precious metals mines in the Americas employing approximately 2,000 people. Coeur produces from its wholly owned operations: the Palmarejo silver-gold complex in Mexico, the Rochester silver-gold mine in Nevada, the Kensington gold mine in Alaska, the Wharf gold mine in South Dakota, and the San Bartolomé silver mine in Bolivia. The company also has a non-operating interest in the Endeavor mine in Australia. In addition, the company has two silver-gold exploration stage projects - the La Preciosa project in Mexico and the Joaquin project in Argentina. Coeur conducts ongoing exploration activities in Alaska, Nevada, South Dakota and Mexico. For more information, visit the company's website www.coeur.com.

Cogentix Medical (CGNT)

Cogentix Medical (NASDAQ: CGNT) is a global medical device company. The company is headquartered in Minnetonka, Minnesota, with additional operations in New York, Massachusetts, The Netherlands and the United Kingdom. Cogentix designs, develops, manufactures and markets products for flexible endoscopy using its PrimeSight, providing users with efficient and cost effective endoscope turnover while enhancing patient safety. The company also commercializes the Urgent® PC Neuromodulation System, an FDA-cleared device that delivers percutaneous tibial nerve stimulation for the office-based treatment of overactive bladder (OAB). Additionally, the company offers Macroplastique®, an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency. For more information, visit the company's website www.cogentixmedical.com.

Columbus McKinnon (CMCO)

Columbus McKinnon (NASDAQ: CMCO) designs, manufactures, and markets material handling products for various commercial and industrial end-user markets in the United States and internationally. The company offers material handling products, technologies, systems and services, which efficiently and ergonomically move, lift, position and secure materials and people. Key products include hoists, cranes, actuators, rigging tools, light rail work stations and digital power and motion control systems. The company sells its products to various industries such as manufacturing, power generation and distribution, utilities, wind power, warehouses, commercial construction, oil and gas exploration and refining, petrochemical, marine, ship building, transportation and heavy duty trucking, agriculture, logging, and mining, as well as to the entertainment industry used for permanent and traveling concerts, live theater, and sporting venues. For more information, visit the company's website www.cmworks.com.

Command Center (CCNI)

Command Center (OTCQB: CCNI) provides flexible on-demand employment solutions for small to mid-sized businesses in the United States, primarily in the areas of light industrial, hospitality and event services. The company provides on-demand employees for manual labor, light industrial, and skilled trades applications. Through 63 field offices, the company provides employment annually for over 33,000 field team members working for 3,300 clients. For more information, visit the company's website www.commandonline.com.

Compass Diversified Holdings (CODI)

Compass Diversified Holdings (NYSE: CODI) is a private equity firm specializing in acquisitions, buyouts, and middle market investments in North America. The company maintains controlling ownership interests in each of its subsidiaries in order to maximize its ability to impact long term cash flow generation and value. Compass provides both debt and equity capital for its subsidiaries, contributing to their financial and operating flexibility and utilizes the cash flows generated by its subsidiaries to invest in the long-term growth of the company and to make cash distributions to its shareholders. For more information, visit the company's website www.compassdiversifiedholdings.com.

Conatus Pharmaceuticals (CNAT)

Conatus Pharmaceuticals (NASDAQ: CNAT) is a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease. The company is developing its lead compound, emricasan, for the treatment of patients with chronic liver disease. Emricasan is designed to reduce the activity of enzymes that mediate inflammation and apoptosis. Conatus believes that by reducing the activity of these enzymes, emricasan has the potential to interrupt the disease progression across the spectrum of liver disease. For more information, visit the company's website www.conatuspharma.com.

Concert Pharmaceuticals (CNCE)

Concert Pharmaceuticals (NASDAQ: CNCE) is a clinical stage biopharmaceutical company focused on applying its DCE Platform® (deuterated chemical entity platform) to create novel medicines designed to address unmet patient needs. The company's approach starts with approved drugs in which deuterium substitution has the potential to enhance clinical safety, tolerability or efficacy. Concert has a broad pipeline of innovative medicines targeting pulmonary diseases, including cystic fibrosis, central nervous systems (CNS) disorders, as well as autoimmune and inflammatory diseases. For more information, visit the company's website www.concertpharma.com.

Connection (CNXN)

Connection (NASDAQ: CNXN), is the combined corporate brand name for PC Connection, Inc. along with its subsidiaries PC Connection Sales, GovConnection, and MoreDirect. Headquartered in Merrimack, NH with offices throughout the United States, the company continues to deliver custom-configured computer systems overnight from its certified technical configuration lab at its distribution center in Wilmington, OH. In addition, the company has over 2,500 technical certifications that permits it to solve the most complex issue. Connections also services international customers through its GlobalServe subsidiary, a global IT procurement and service management company. For more information, visit the company's website www.connection.com.

Consolidated Water (CWCO)

Consolidated Water (NASDAQ: CWCO) develops and operates seawater desalination plants and water distribution systems in areas of the world where naturally occurring supplies of potable water are scarce or nonexistent. The company operates water production and distribution facilities and provides water-related products and services to customers in the Cayman Islands, Belize, the British Virgin Islands, The Commonwealth of The Bahamas, Indonesia and the United States. For more information, visit the company's website www.cwco.com.

Contango Oil & Gas (CWCO)

Contango Oil & Gas (NYSE: MCF) is a Houston, Texas based independent oil and natural gas company. The company acquires, explores, develops, exploits, and produces crude oil and natural gas properties in the offshore shallow waters of the Gulf of Mexico, and in the onshore Texas Gulf Coast and Rocky Mountain regions in the United States. For more information, visit the company's website www.contango.com.

Cooper Standard (CPS)

Cooper Standard (NYSE: CPS), headquartered in Novi, Michigan, is a global supplier of systems and components for the automotive industry. The company's product line includes rubber and plastic sealing, fuel and brake lines, fluid transfer hoses and anti-vibration systems. Cooper Standard employs approximately 30,000 people globally and operates in 20 countries around the world. For more information, visit the company's website www.cooperstandard.com.

COPsync (COYN)

COPsync (NASDAQ: COYN) is a real-time law enforcement mobile data information system in the United States. It provides COPsync Network, a software service which enables patrol officers to collect, report, and share critical data in real-time at the point of incident and obtain instant access to various local, state, and federal law enforcement databases. The company's COPsync Network service also enables officers to electronically write tickets; process DUI and other arrests; and document accidents and other incidents, as well as allows dispatchers and officers to send be on the lookout and other alerts of child kidnappings, robberies, car thefts, police pursuits, and other crimes in progress. For more information, visit the company's website at www.copsync.com.

Craft Brew Alliance (BREW)

Craft Brew Alliance (NASDAQ: BREW) ("CBA") is an independent craft brewing company that brews, brands, and brings to market American craft beers. The company's portfolio combines the power of Kona Brewing Company, a dynamic, fast-growing national craft beer brand, with an expanding stable of strong regional breweries and innovative lifestyle brands, including Appalachian Mountain Brewery, Cisco Brewers, Omission Brewing Co., Redhook Brewery, Square Mile Cider Co. and Widmer Brothers Brewing. CBA nurtures the growth and development of its brands in today's increasingly competitive beer market through its state-of-the-art brewing and distribution capability, integrated sales and marketing infrastructure, and strong focus on partnerships, local community and sustainability. Formed in 2008, CBA is headquartered in Portland, Oregon and operates breweries and brewpubs across the U.S. CBA beers are available in all 50 U.S. states and 30 different countries around the world. For more information, visit the company's website www.craftbrew.com.

Crius Energy (CRIUF)

Crius Energy (OTC: CRIUF) is one of the largest independent energy retailers in the United States, providing electricity, natural gas and solar products to more than 950,000 residential and commercial customers. The company connects with energy customers through an innovative family-of-brands strategy and multi-channel marketing approach. The result is a broad, well-differentiated platform that minimizes risk while providing customers with unique and customized brand experiences. For more information, visit the company's website at www.criusenergy.com.

Crown Crafts (CRWS)

Crown Crafts (NASDAQ: CRWS) designs, markets and distributes infant, toddler and juvenile consumer products. Its product line includes crib and toddler bedding, bathing accessories, reusable and disposable bibs, and disposable placemats, floor mats, toilet seat covers and changing mats. The company's operating subsidiaries consist of Crown Crafts Infant Products, Inc. in California and Hamco, Inc. in Louisiana. Crown Crafts is among America's largest producers of infant bedding, toddler bedding and bibs. The company's products include licensed and branded collections, as well as exclusive private label programs for certain of its customers. For more information, visit the company's website at www.crowncrafts.com.

Cryoport (CYRX)

Cryoport (NASDAQ: CYRX) is a global provider of cold chain logistics solutions for temperature-sensitive life sciences commodities. The company serves the biopharmaceutical market with logistics solutions for biologic materials, such as regenerative medicine, including immunotherapies, stem cells and CAR-T cells. The company's solutions are used by points-of-care, CRO's, central laboratories, pharmaceutical companies, manufacturers, and university researchers. The company also serves the reproductive medicine market, primarily in IVF and surrogacy; and the animal health market, primarily in the areas of vaccines and reproduction. Cryoport's proprietary Cryoport Express® Shippers, Cryoportal™ Logistics Management Platform, SmartPak II™ Condition Monitoring System and geo-sensing technology, paired with cold chain logistics and client support, make the company an end-to-end cold chain logistics partner. For more information, visit the company's website at www.cryoport.com.

CTI BioPharma (CTIC)

CTI BioPharma (NASDAQ: CTIC) is a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies covering a spectrum of blood-related cancers that offer a unique benefit to patients and healthcare providers. The company has a commercial presence in Europe with respect to PIXUVRI® and a late-stage development pipeline, including pacritinib for the treatment of patients with myelofibrosis. CTI BioPharma is headquartered in Seattle, Washington. For more information, visit the company's website at www.ctibiopharma.com.


CTS (NYSE: CTS) designs and manufactures products that sense, connect and move. The company manufactures sensors, actuators and electronic components in North America, Europe and Asia. CTS supplies these products to OEMs in the aerospace, communications, defense, industrial, information technology, medical and transportation markets. For more information, visit the company's website at www.ctscorp.com.

Cutera (CUTR)

Cutera (NASDAQ: CUTR) is a medical device company that designs, develops, manufactures, markets, and services laser and other energy based aesthetics systems for practitioners worldwide. Since 1998, the Brisbane, California-based company has been developing innovative, easy-to-use products that enable physicians and other qualified practitioners to offer safe and effective aesthetic treatments to their patients. The company offers enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions; excel HR platform, a hair removal solution for various skin types; and truSculpt, a high-powered radio frequency platform designed for deep tissue heating. For more information, visit the company's website at www.cutera.com.

CymaBay Therapeutics (CBAY)

CymaBay Therapeutics (NASDAQ: CBAY) is a clinical-stage biopharmaceutical company developing therapies to treat specialty and orphan diseases with high unmet medical need. Seladelpar is a potent, selective, orally active PPARδ agonist. CymaBay has recently completed a phase 2 study of seladelpar in patients with primary biliary cholangitis as well as a pilot phase 2 study in patients with homozygous familial hypercholesterolemia, establishing proof-of-concept in both indications. For more information, visit the company's website at www.cymabay.com.

Cytokinetics (CYTK)

Cytokinetics (NASDAQ: CYTK) is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company is developing small molecule drug candidates specifically engineered to increase muscle function and contractility. Cytokinetics' lead drug candidate is tirasemtiv, a fast skeletal troponin activator (FSTA). Tirasemtiv is the subject of VITALITY-ALS, an international phase 3 clinical trial in patients with ALS. Tirasemtiv has been granted FDA orphan drug designation and fast track status, as well as orphan medicinal product designation by the EMA. Cytokinetics is preparing for the potential commercialization of tirasemtiv in North America and Europe and has granted an option to Astellas Pharma Inc. for development and commercialization in other countries. The company is collaborating with Astellas to develop CK-2127107, a next-generation fast skeletal muscle activator, currently in two ongoing phase 2 clinical trials. Additionally, Cytokinetics is collaborating with Amgen Inc. to develop omecamtiv mecarbil, a novel cardiac muscle activator. Omecamtiv mecarbil is the subject of GALACTIC-HF, an international phase 3 clinical trial in patients with heart failure. For more information, visit the company's website at www.cytokinetics.com.

Cytori Therapeutics (CYTX)

Cytori Therapeutics (NASDAQ: CYTX) develops cellular therapeutics for specific diseases and medical conditions. The company primarily provides Cytori Cell Therapy consisting of a heterogeneous population of specialized cells, including stem cells for the treatment of patients with scleroderma hand dysfunction, orthopedic disorders, urinary incontinence, and thermal burns combined with radiation injury. It also offers Celution System devices, proprietary enzymes, and sterile consumable sets to commercial customers, as well as for research customers developing new therapeutic applications for Cytori Cell Therapy. For more information, visit the company's website at www.cytori.com.

CytRx (CYTR)

CytRx (NASDAQ: CYTR) is a biopharmaceutical research and development company specializing in oncology. CytRx currently is focused on the clinical development of aldoxorubicin, its improved version of the widely used chemotherapeutic agent doxorubicin. CytRx is also expanding its pipeline of oncology candidates at its laboratory facilities in Freiburg, Germany, through its LADR™ (Linker Activated Drug Release) technology platform, a discovery engine designed to leverage CytRx's expertise in albumin biology and linker technology for the development of a new class of anti-cancer therapies. For more information, visit the company's website at www.cytrx.com.

Daqo New Energy (DQ)

Daqo New Energy (NYSE: DQ) is a manufacturer of high-purity polysilicon for the global solar PV industry. Founded in 2008, the low cost producer of high-purity polysilicon and solar wafers primarily sells its products to solar cell and solar module manufacturers. Daqo New Energy has built a manufacturing facility that is technically advanced and highly efficient with a nameplate capacity of 12,150 metric tons in Xinjiang, China. The company also operates a solar wafer manufacturing facility in Chongqing, China. For more information, visit the company's website at www.dqsolar.com.

Darling Ingredients (DAR)

Darling Ingredients (NYSE: DAR) is a developer and producer of sustainable natural ingredients from edible and inedible bio-nutrients, creating a wide range of ingredients and specialty products for customers in the pharmaceutical, food, pet food, feed, technical, fuel, bioenergy, and fertilizer industries. With operations on five continents, the company collects and transforms all aspects of animal by-product streams into broadly used and specialty ingredients, such as gelatin, edible fats, feed-grade fats, animal proteins and meals, plasma, pet food ingredients, organic fertilizers, yellow grease, fuel feedstocks, green energy, natural casings and hides. The company also recovers and converts used cooking oil and commercial bakery residuals into valuable feed and fuel ingredients. In addition, the company provides grease trap services to food service establishments, environmental services to food processors and sells restaurant cooking oil delivery and collection equipment. For more information, visit the company's website at www.darlingii.com.

Data I/O (DAIO)

Data I/O (NASDAQ: DAIO) is a tech company that designs, manufactures and sells programming systems for electronic device manufacturers worldwide. The company's programming system products are used to program integrated circuits (ICs) with the specific data necessary for the ICs. The company also offers non-automated programming systems comprising FlashPAK III programmer; and Sprint/Unifamily programmers, an off-line, low volume, and engineering non-automated system. For more information, visit the company's website at www.dataio.com.

Delcath Systems (DCTH)

Delcath Systems (NASDAQ: DCTH) operates as a specialty pharmaceutical and medical device company focusing on cancers of the liver. The company is developing its proprietary product-Melphalan Hydrochloride for injection for use with the Delcath Hepatic Delivery System; and markets melphalan hydrochloride as a device under the trade name Delcath Hepatic CHEMOSAT Delivery System for Melphalan in Europe. Its primary focus is on the execution of its clinical development program in ocular melanoma liver metastases, intrahepatic cholangiocarcinoma, hepatocellular carcinoma, and certain other cancers that are metastatic to the liver. For more information, visit the company's website at www.delcath.com.

Delta Apparel (DLA)

Delta Apparel (NYSE: DLA) is an international design, marketing, manufacturing, and sourcing company that features a diverse portfolio of lifestyle basic and branded activewear apparel, headwear and related accessories along with its operating subsidiaries, M. J. Soffe, LLC, Junkfood Clothing Company, Salt Life, LLC and Art Gun, LLC. The company specializes in selling casual and athletic products across distribution tiers, including specialty stores, boutiques, department stores, mid-tier and mass chains, and the U.S. military. Additionally, the company's products are made available direct-to-consumer on its websites. The company's operations are located throughout the United States, Honduras, El Salvador, and Mexico, and it employs approximately 7,800 people worldwide. For more information, visit the company's website at www.deltaapparelinc.com.

Denison Mines (DNN)

Denison Mines (NYSE: DNN) is a uranium exploration and development company with interests focused in the Athabasca Basin region of northern Saskatchewan. Including its 60% owned Wheeler River project, which hosts the high grade Phoenix and Gryphon uranium deposits, Denison's exploration portfolio consists of numerous projects covering over 350,000 hectares in the infrastructure rich eastern Athabasca Basin. Denison's interests in Saskatchewan also include a 22.5% ownership interest in the McClean Lake joint venture, which includes several uranium deposits and the McClean Lake uranium mill, which is currently processing ore from the Cigar Lake mine under a toll milling agreement, plus a 25.17% interest in the Midwest deposit and a 63.01% interest in the J Zone deposit on the Waterbury Lake property. Both the Midwest and J Zone deposits are located within 20 kilometers of the McClean Lake mill. For more information, visit the company's website at www.denisonmines.com.

Denny's (DENN)

Denny's (NASDAQ: DENN) is the franchisor and operator of one of America's largest franchised full-service restaurant chains, based on the number of restaurants. As of December 28, 2016, Denny's had 1,733 franchised, licensed, and company restaurants around the world with combined sales of $2.8 billion including 123 restaurants in Canada, Puerto Rico, Mexico, New Zealand, Honduras, Costa Rica, Dominican Republic, the United Arab Emirates, Guam, the Philippines, Curaçao, El Salvador, and Trinidad and Tobago. For more information, visit the company's website at investor.dennys.com.

Depomed (DEPO)

Depomed (NASDAQ: DEPO) is a specialty pharmaceutical company focused on enhancing the lives of the patients, families, physicians, providers and payors through commercializing innovative products for pain and neurology related disorders. Depomed markets six medicines with areas of focus that include mild to severe acute pain, moderate to severe chronic pain, neuropathic pain, migraine and breakthrough cancer pain. Depomed is headquartered in Newark, California. For more information, visit the company's website at www.depomed.com.

Diamcor Mining (DMIFF)

Diamcor Mining (OTCQX: DMIFF) is a junior diamond mining company engaged in the identification, acquisition, exploration, evaluation, operation, and development of diamond based resource properties in South Africa. The company has an established operational and production history in South Africa and extensive prior experience supplying rough diamonds to the world market. The company holds interests in the Krone-Endora at Venetia project that consists of Krone 104MS and Endora 66MS farms covering a combined surface area of approximately 5,888 hectares located in Venetia. Additionally, the company has a strategic alliance with Tiffany & Co. For more information, visit the company's website at www.diamcormining.com.

Diamondback Energy (FANG)

Diamondback Energy (NASDAQ: FANG) is an independent oil and natural gas company headquartered in Midland, Texas. The company is focused on the acquisition, development, exploration and exploitation of unconventional, onshore oil and natural gas reserves in the Permian Basin in West Texas. Diamondback's activities are primarily focused on the horizontal exploitation of multiple intervals within the Wolfcamp, Spraberry, Clearfork, Bone Spring and Cline formations. For more information, visit the company's website at www.diamondbackenergy.com.

Differential Brands Group (DFBG)

Differential Brands Group (NASDAQ: DFBG) is engaged in operating companies in the premium apparel, footwear and accessories sectors. The company's focus is on organically growing its brands through a global, omni-channel distribution strategy while continuing to seek opportunities to acquire accretive, complementary, premium brands. Current brands include Hudson®, a designer and marketer of women's and men's premium, branded denim and apparel; Robert Graham®, a sophisticated, eclectic apparel and accessories brand; and SWIMS®, a Scandinavian lifestyle brand best known for its range of fashion-forward, water-resistant footwear, apparel and accessories. For more information, visit the company's website at www.differentialbrandsgroup.com.

Digirad (DRAD)

Digirad (NASDAQ: DRAD) delivers convenient, effective and efficient healthcare solutions on an as needed, when needed, and where needed basis. The company's diverse portfolio of mobile healthcare solutions and medical equipment and services — including diagnostic imaging and patient monitoring — provides hospitals, physician practices and imaging centers throughout the United States access to technology and services necessary to provide exceptional patient care in the rapidly changing healthcare environment. For more information, visit the company's website at www.digirad.com.

Digital Turbine (APPS)

Digital Turbine (NASDAQ: APPS) works at the convergence of media and mobile communications, delivering end-to-end products and solutions for mobile operators, device OEMs, app advertisers and publishers, that enable efficient user acquisition, app management and monetization opportunities. The company's products include Ignite™, a mobile device management solution with targeted app distribution capabilities, Marketplace™, an application and content store, and Pay™, a content management and mobile payment solution. The company incorporates an independent user acquisition network as well as an advertiser solution for unique and exclusive carrier inventory. Digital Turbine has delivered more than 150 million app installs for hundreds of advertisers. In addition, more than 31 million customers use Digital Turbine's solutions each month across more than 30 global operators. The company is headquartered in Austin, Texas with global offices in Durham, Berlin, San Francisco, Singapore, Sydney and Tel Aviv. For more information, visit the company's website at www.digitalturbine.com.

Diodes (DIOD)

Diodes (NASDAQ: DIOD) is a global manufacturer and supplier of high-quality application specific standard products within the broad discrete, logic, analog and mixed-signal semiconductor markets. Diodes serves the consumer electronics, computing, communications, industrial, and automotive markets. The company's products include diodes, rectifiers, transistors, MOSFETs, and protection devices. The company also provides power management devices including LED drivers, AC-DC converters and controllers, DC-DC switching and linear voltage regulators. For more information, visit the company's website at www.diodes.com.

Diversified Restaurant Holdings (SAUC)

Diversified Restaurant Holdings (NASDAQ: SAUC) operates as a restaurant company in the United States. The company operates Buffalo Wild Wings Grill & Bar franchised restaurants, which primarily offer chicken wings, boneless wings, and other items, including chicken tenders, flatbreads, popcorn shrimps, specialty hamburgers and sandwiches, wraps, soft tacos, appetizers and salads. As of June 21, 2016, Diversified Restaurant Holdings operated 64 Buffalo Wild Wings Grill & Bar franchised restaurants in Florida, Illinois, Indiana, Michigan and Missouri. For more information, visit the company's website at www.diversifiedrestaurantholdings.com.

DLH Holdings (DLHC)

DLH Holdings (NASDAQ: DLHC) serves clients throughout the United States as a healthcare and human services provider to the Federal Government. Core competencies include assessment & compliance monitoring, business process outsourcing, health IT systems integration and management, readiness and medical logistics, and pharmacy solutions. DLH has over 1,400 employees working throughout the country. For more information, visit the company's website at www.dlhcorp.com.

DMC Global (BOOM)

DMC Global (NASDAQ: BOOM) is a Boulder, Colorado based company that operates in two sectors: industrial infrastructure and oilfield products and services. The industrial infrastructure sector is served by DMC's NobelClad business, the world's largest manufacturer of explosion-welded clad metal plates, which are used to fabricate capital equipment utilized within various process industries and other industrial sectors. The oilfield products and services sector is served by DynaEnergetics, an international developer, manufacturer and marketer of advanced explosive components and systems used to perforate oil and gas wells. For more information, visit the company's website at www.dmcglobal.com.

Dolphin Digital Media (DPDM)

Dolphin Digital Media (OTC: DPDM) is a digital entertainment company delivering premium original content to more than 500 million homes in 125 countries. The company recently produced the popular "South Beach" series on Hulu, and has also produced multiple Streamy-Award nominated projects including "Aim High" starring Jackson Rathbone and Aimee Teegarden (AOL), and "Cybergeddon" from Anthony E. Zuiker starring Missy Peregrym and Olivier Martinez (Yahoo). Dolphin Digital Media recently completed its acquisition of Dolphin Films, a division dedicated to the production and distribution of motion pictures. For more information, visit the company's website at www.dolphindigitalmedia.com.

DSP Group (DSPG)

DSP Group (NASDAQ: DSPG) is a global provider of wireless chipset solutions for converged communications. Delivering semiconductor system solutions with software and hardware reference designs, the company enables OEMs/ODMs, consumer electronics (CE) manufacturers and service providers to cost-effectively develop new revenue-generating products with fast time to market. DSP Group provides a broad portfolio of wireless chipsets integrating DECT/CAT-iq, ULE, Wi-Fi, PSTN, HDClear™, video and VoIP technologies. The company enables converged voice, audio, video and data connectivity across diverse mobile, consumer and enterprise products – from mobile devices, connected multimedia screens, and home automation & security to cordless phones, VoIP systems, and home gateways. For more information, visit the company's website at www.dspg.com.

Ducommun (DCO)

Ducommun (NYSE: DCO) delivers value-added innovative manufacturing solutions to customers in the aerospace, defense and industrial markets. Founded in 1849, the company specializes in two core areas: electronic systems and structural systems. The company produces complex products and components for commercial aircraft platforms, mission-critical military and space programs, and sophisticated industrial applications. For more information, visit the company's website at www.ducommun.com.

Dynatronics (DYNT)

Dynatronics (NASDAQ: DYNT) designs, manufactures, distributes, markets and sells advanced-technology medical devices, treatment tables and rehabilitation equipment as well as thousands of products and supplies. The company provides these physical medicine and rehabilitation products primarily to physical therapists, chiropractors, athletic trainers and sports medicine practitioners. For more information, visit the company's website at www.dynatronics.com.

Earthstone Energy (ESTE)

Earthstone Energy (NYSE: ESTE) is a growth-oriented independent oil and gas exploration and production company. The company is engaged in developing and acquiring oil and gas reserves through an active and diversified program that includes acquiring, drilling and developing undeveloped leases, asset and corporate acquisitions and exploration activities. The company's current primary assets are located in the Midland Basin of west Texas, the Eagle Ford trend of south Texas, and the Williston Basin of North Dakota. For more information, visit the company's website at www.earthstoneenergy.com.

Eastside Distilling (ESDI)

Eastside Distilling (OTC: ESDI) develops, manufactures, produces and markets hand-crafted spirits in the United States. The company offers bourbon under the Burnside Bourbon and Oregon Oak Burnside Bourbon brand names; premium whiskey under the Barrel Hitch American Whiskey and Barrel Hitch Oregon Oaked Whiskey brand names; distinctive whiskey under the Cherry Bomb Whiskey and Marionberry Whiskey brand names; and rum under the Below Deck Silver Rum, Below Deck Spiced Rum, Below Deck Coffee Rum, and Below Deck Ginger Rum brand names. For more information, visit the company's website at www.eastsidedistilling.com.

Eiger BioPharmaceuticals (EIGR)

Eiger BioPharmaceuticals (NASDAQ: EIGR) is a clinical-stage biopharmaceutical company committed to bringing to market novel products for the treatment of rare diseases. The company has built a diverse portfolio of well-characterized product candidates with the potential to address diseases for which the unmet medical need is high, the biology for treatment is identified, and for which an effective therapy is urgently needed. For more information, visit the company's website at www.eigerbio.com.

Ekso Bionics (EKSO)

Ekso Bionics (NASDAQ: EKSO) develops exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance and mobility across medical, industrial and defense applications. Founded in 2005, the company designs innovative wearable robots. Ekso Bionics offers technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe, to providing research for the advancement of R&D projects intended to benefit U.S. defense capabilities. For more information, visit the company's website at www.eksobionics.com.

Electrovaya (EFLVF)

Electrovaya (OTC: EFLVF) designs, develops and manufactures proprietary Lithium Ion Super Polymer® batteries, battery systems, and battery-related products for energy storage, clean electric transportation and other specialized applications. Electrovaya, through its fully owned subsidiary, Litarion GmbH, also produces cells, electrodes and SEPARION® ceramic separators and has manufacturing capacity of about 500MWh/annum. Electrovaya is a technology focused company with extensive patents and other Intellectual Property. Headquartered in Ontario, Canada, the company has production facilities in Canada and Germany with customers around the globe. For more information, visit the company's website at www.electrovaya.com.

Eleven Biotherapeutics (EBIO)

Eleven Biotherapeutics (NASDAQ: EBIO) is a late-stage clinical oncology company advancing a broad pipeline of novel product candidates based upon the company's targeted protein therapeutics (TPTs) platform. The company's TPTs incorporate a tumor-targeting antibody fragment and a protein cytotoxic payload into a single protein molecule in order to achieve focused tumor cell killing. The company believes its TPTs provide effective tumor targeting with broader cancer cell-killing properties than are achievable with small molecule payloads that require tumor cell proliferation and face multi-drug resistance mechanisms. Additionally, the company believes that its TPT's cancer cell-killing properties promote an anti-tumor immune response that will potentially combine well with immune oncology drugs such as checkpoint inhibitors. For more information, visit the company's website at www.elevenbio.com.

Elio Motors (ELIO)

Elio Motors (OTC: ELIO) is engaged in manufacturing an ultra-high-mileage vehicle. The three-wheel Elio is engineered to attain a highway mileage rating of up to 84 mpg, while providing the comfort of amenities such as power windows, power door lock, air conditioning and cruise control, accompanied by the safety of multiple air bags and an aerodynamic, enclosed vehicle body. Elio was founded by car enthusiast Paul Elio in 2009 and its first manufacturing site will be in Shreveport, LA. For more information, visit the company's website at www.eliomotors.com.

Ellie Mae (ELLI)

Ellie Mae (NYSE: ELLI) is a provider of innovative on-demand software solutions and services for the residential mortgage industry. Mortgage lenders of all sizes use Ellie Mae's Encompass® all-in-one mortgage management solution, Mavent Compliance Service, and AllRegs research, reference and education resources to improve compliance, loan quality and efficiency across the entire mortgage lifecycle. For more information, visit the company's website at www.elliemae.com.


EMCORE (NASDAQ: EMKR) provides advanced mixed-signal optics products that provide the foundation for today's high-speed communication network infrastructures and leading-edge defense systems. The company's optical chips, components, subsystems and systems enable broadband and wireless providers to continually enhance their network capacity, speed and coverage. EMCORE's optical components and systems serve a broad array of applications including cable television, fiber-to-the-premise networks, telecommunications, wireless infrastructure, satellite RF fiber links, navigation systems and military communications. The company has fully vertically-integrated manufacturing capability through its Indium Phosphide (InP) wafer fabrication facility at its headquarters in Alhambra, California. For more information, visit the company's website at www.emcore.com.

Emefcy Group (EMFGF)

Emefcy Group (OTC: EMFGF) develops, manufactures and markets new, energy-efficient MABR based wastewater treatment solutions, aiming to change the economics of various markets and addressing the growing global demand for clean water in municipal and industrial plants. Customer contracts have already been signed in Israel, US Virgin Islands, Ethiopia, and China, and plants in Israel, the US Virgin Islands and now China have been successfully commissioned. Additional MABR-based wastewater solutions from Emefcy's extensive R&D operations are scheduled to be announced during the year. For more information, visit the company's website at www.emefcy.com.


Contact us: 212.418.1217